Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability

Acta Haematologica

Volumn 120, Issue 2, 2008, Pages 91-99

  Narita, Miwako ^a   Kuroha, Takashi ^b   Watanabe, Norihiro ^a   Hashimoto, Shigeo ^b   Tsuchiyama, Junjiro ^b   Tochiki, Nozomi ^a   Saitoh, Anri ^a   Satoh, Noriyuki ^a   Furukawa, Tatsuo ^c   Toba, Ken ^b   Fuse, Ichiro ^c   Aizawa, Yoshifusa ^b   Takahashi, Masuhiro ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Antigen presenting ability; CD33; IL 3; Myeloid dendritic cells; Plasmacytoid dendritic cell leukemia

Indexed keywords

CD123 ANTIGEN; CD33 ANTIGEN; CD36 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 3;

AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CASE REPORT; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MALE; NATURAL KILLER CELL; PLASMACYTOID DENDRITIC CELL LEUKEMIA; PRIORITY JOURNAL; SKIN BIOPSY; T LYMPHOCYTE;

AGED; ANTIGEN PRESENTATION; CELL LINEAGE; CORD BLOOD STEM CELL TRANSPLANTATION; DENDRITIC CELLS; GRAFT VS LEUKEMIA EFFECT; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-3; LEUKEMIA; MALE;

EID: 54249156525     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000165510     Document Type: Article

References (38)

1. Soumelis V, Liu YJ: From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur J Immunol 2006;36:2286-2292.
2. Gattei V, Carbone A, Zagonel V, Pinto A: Expression of natural killer antigens in a subset of 'non-T, non-B lymphoma/leukaemia with histiocytic features'. Br J Haematol 1990;76:444-448.
3. Brody JP, Allen S, Schulman P, Sun T, Chan WC, Friedman HD, Teichberg S, Koduru P, Cone RW, Loughran TP Jr: Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer 1995;75:2474-2483.
4. Kameoka J, Ichinohasama R, Tanaka M, Miura I, Tomiya Y, Takahashi S, Yamada M, Ishikawa I, Kadowaki I, Sasaki O, Kimura J, Meguro K, Ooya K, Ito S: A cutaneous agranular CD2- CD4+ CD56+ 'lymphoma': report of two cases and review of the literature. Am J Clin Pathol 1998;110:478-488.
5. Petrella T, Dalac S, Maynadie M, Mugneret F, Thomine E, Courville P, Joly P, Lenormand B, Arnould L, Wechsler J, Bagot M, Rieux C, Bosq J, Avril MF, Bernheim A, Molina T, Devidas A, Delfau-Larue MH, Gaulard P, Lambert D: CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol 1999;23:137-146.
6. Kimura S, Kakazu N, Kuroda J, Akaogi T, Hayashi H, Nishida K, Abe T: Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma. Ann Hematol 2001;80:228-231.
7. Knudsen H, Gronbaek K, thor Straten P, Gisselo C, Johansen P, Timshel S, Bergmann OJ, Hansen NE, Ralfkiaer E: A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion. Br J Dermatol 2002;146:148-153.
8. Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eilender D, Palutke M: CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Am J Clin Pathol 2001;116:168-176.
9. Drenou B, Lamy T, Amiot L, Fardel O, Caulet-Maugendre S, Sasportes M, Diebold J, Le Prise PY, Fauchet R: CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 1997;89:2966-2974.
10. Nakamura S, Suchi T, Koshikawa T, Kitoh K, Koike K, Komatsu H, Iida S, Kagami Y, Ogura M, Katoh E, Kurita S, Suzuki H, Kobashi Y, Yamabeh H, Hirabayashi N, Ueda R, Takahashi T: Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-296.
11. Lucio P, Parreira A, Orfao A: CD123hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma. Ann Intern Med 1999;131:549-550.
12. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto JJ, Bensa JC, Briere F, Plumas J, Jacob MC: Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001;97:3210-3217.
13. Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drenou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Bene MC: Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002;99:1556-1563.
14. Petrella T, Comeau MR, Maynadie M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L: 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002;26:852-862.
15. Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Bene MC, Bensa JC, Briere F, Plumas J: CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003;88:941-955.
16. Nava VE, Jaffe ES: The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol 2005;12:27-34.
17. Slater DN: The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol 2005;153:874-880.
18. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ: WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-3785.
19. Garnache-Ottou F, Chaperot L, Biichle S, Ferrand C, Remy-Martin JP, Deconinck E, de Tailly PD, Bulabois B, Poulet J, Kuhlein E, Jacob MC, Salaun V, Arock M, Drenou B, Schillinger F, Seilles E, Tiberghien P, Bensa JC, Plumas J, Saas P: Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Blood 2005;105:1256-1264.
20. Narbutt J, Lesiak A, Zak-Prelich M, Wozniacka A, Sysa-Jedrzejowska A, Tybura M, Robak T, Smolewski P: The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the Polish population. Cell Mol Biol Lett 2004;9:497-509.
21. Narita M, Takahashi M, Liu A, Nikkuni K, Furukawa T, Toba K, Koyama S, Takai K, Sanada M, Aizawa Y: Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia. Exp Hematol 2001;29:709-719.
22. Garnache-Ottou F, Feuillard J, Saas P: Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? Br J Haematol 2007;136:539-548.
23. Momoi A, Toba K, Kawai K, Tsuchiyama J, Suzuki N, Yano T, Uesugi Y, Takahashi M, Aizawa Y: Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases. Leuk Res 2002;26:693-698.
24. Petrella T, Teitell MA, Spiekermann C, Meijer CJ, Franck F, Enache I: A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol 2004;150:174-176.
25. Reichard KK, Burks EJ, Foucar MK, Wilson CS, Viswanatha DS, Hozier JC, Larson RS: CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol 2005;29:1274-1283.
26. bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion? J Immunol 2002;169:75-83.
27. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN: Characterization of human blood dendritic cell subsets. Blood 2002;100:4512-4520.
28. Giagounidis AA, Heinsch M, Haase S, Aul C: Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes. Ann Hematol 2004;83:716-721.
29. Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, Le Mee F, Plessis G, Talmant P, Gachard N, Uettwiller F, Pages MP, Mozziconacci MJ, Eclache V, Sibille C, Avet-Loiseau H, Lafage-Pochitaloff M: CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood 2002;99:4154-4159.
30. Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP: Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 2007;109:1720-1727.
31. Barral DC, Brenner MB: CD1 antigen presentation: how it works. Nat Rev Immunol 2007;7:929-941.
32. Eliopoulos AG, Young LS: The role of the CD40 pathway in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 2004;4:360-367.
33. Bajtay Z, Csomor E, Sandor N, Erdei A: Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol Lett 2006;104:46-52.
34. Bendriss-Vermare N, Barthelemy C, Durand I, Bruand C, Dezutter-Dambuyant C, Moulian N, Berrih-Aknin S, Caux C, Trinchieri G, Briere F: Human thymus contains IFN-α-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest 2001;107:835-844.
35. Chaperot L, Perrot I, Jacob MC, Blanchard D, Salaun V, Deneys V, Lebecque S, Briere F, Bensa JC, Plumas J: Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol 2004;34:418-426.
36. Kazakov DV, Mentzel T, Burg G, Dummer R, Kempf W: Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol 2003;149:869-876.
37. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D: CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002;94:2401-2408.
38. Reimer P, Rudiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, Konrad Muller-Hermelink H, Wilhelm M: What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant 2003;32:637-646.